# DSS, Inc.: financial statements, quarterly

DSS · NYSE · CIK 771999 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dss.md) · [Financials](/companies/dss/financials.md) · [Filings](/companies/dss/filings.md) · [Insiders](/companies/dss/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dss/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.2](/filings/0001493152-24-045198.md) | [7.0 d](/filings/0001641172-25-001576.md) | [3.9](/filings/0001641172-25-010712.md) | [4.2](/filings/0001641172-25-024046.md) | [5.6](/filings/0001493152-25-023374.md) | [5.4 d](/filings/0001493152-26-014231.md) | [5.0](/filings/0001493152-26-023865.md) | [5.3](/filings/0001493152-26-038447.md) | [6.4](/filings/0001493152-25-023374.md) | [4.1 d](/filings/0001493152-26-014231.md) | [4.3](/filings/0001493152-26-023865.md) | [3.6](/filings/0001493152-26-038447.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [3.2](/filings/0001493152-24-045198.md) | [35.0 d](/filings/0001641172-25-001576.md) | [3.6](/filings/0001641172-25-010712.md) | [3.5](/filings/0001641172-25-024046.md) | [3.7](/filings/0001493152-25-023374.md) | [27.5 d](/filings/0001493152-26-014231.md) | [3.5](/filings/0001493152-26-023865.md) | [3.2](/filings/0001493152-26-038447.md) | [3.6](/filings/0001493152-25-023374.md) | [2.0 d](/filings/0001493152-26-014231.md) | [4.3](/filings/0001493152-26-023865.md) | [2.9](/filings/0001493152-26-038447.md) |
| Operating income | $m | [(5.1)](/filings/0001493152-24-045198.md) | [(35.2) d](/filings/0001641172-25-001576.md) | [(4.7)](/filings/0001641172-25-010712.md) | [(4.9)](/filings/0001641172-25-024046.md) | [(4.7)](/filings/0001493152-25-023374.md) | [(28.3) d](/filings/0001493152-26-014231.md) | [(3.7)](/filings/0001493152-26-023865.md) | [(3.4)](/filings/0001493152-26-038447.md) | [(3.2)](/filings/0001493152-25-023374.md) | [(4.1) d](/filings/0001493152-26-014231.md) | [(5.5)](/filings/0001493152-26-023865.md) | [(3.8)](/filings/0001493152-26-038447.md) |
| Interest expense | $m | [0.1](/filings/0001493152-24-045198.md) | [0.1 d](/filings/0001641172-25-001576.md) | [0.0](/filings/0001641172-25-010712.md) | [0.1](/filings/0001641172-25-024046.md) | [0.1](/filings/0001493152-25-023374.md) | [0.0 d](/filings/0001493152-26-014231.md) | [0.0](/filings/0001493152-26-023865.md) | [0.1](/filings/0001493152-26-038447.md) | [0.0](/filings/0001493152-25-023374.md) | [0.1 d](/filings/0001493152-26-014231.md) | [0.0](/filings/0001493152-26-023865.md) | [0.1](/filings/0001493152-26-038447.md) |
| Income tax | $m | not reported | [(0.0) d](/filings/0001641172-25-001576.md) | [0.0](/filings/0001641172-25-010712.md) | [(0.2)](/filings/0001641172-25-024046.md) | [0.0 d](/filings/0001493152-25-023374.md) | [0.2 d](/filings/0001493152-26-014231.md) | [(0.1)](/filings/0001493152-26-023865.md) | [0.0 d](/filings/0001493152-26-038447.md) | [0.0 d](/filings/0001493152-25-023374.md) | not reported | not reported | not reported |
| Net income | $m | [(4.3)](/filings/0001493152-24-045198.md) | [(30.3) d](/filings/0001641172-25-001576.md) | [(4.1)](/filings/0001493152-24-019277.md) | [(4.7)](/filings/0001493152-24-031643.md) | [(5.3)](/filings/0001493152-24-045198.md) | [(32.9) d](/filings/0001493152-26-014231.md) | [(4.8)](/filings/0001493152-26-023865.md) | [(2.2)](/filings/0001493152-26-038447.md) | [(2.2)](/filings/0001493152-25-023374.md) | [(13.8) d](/filings/0001493152-26-014231.md) | [(5.8)](/filings/0001493152-26-023865.md) | [(4.8)](/filings/0001493152-26-038447.md) |
| Diluted EPS | $ per share | [(0.62)](/filings/0001493152-24-045198.md) | not reported | [(0.58)](/filings/0001493152-24-019277.md) | [(0.66)](/filings/0001493152-24-031643.md) | [(0.75)](/filings/0001493152-24-045198.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.62)](/filings/0001493152-24-045198.md) | not reported | [(0.58)](/filings/0001493152-24-019277.md) | [(0.66)](/filings/0001493152-24-031643.md) | [(0.75)](/filings/0001493152-24-045198.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.9](/filings/0001493152-23-041176.md) | [6.6](/filings/0001641172-25-001576.md) | [9.3](/filings/0001493152-24-019277.md) | [10.7](/filings/0001493152-24-031643.md) | [11.6](/filings/0001493152-25-023374.md) | [11.4](/filings/0001493152-26-014231.md) | [10.8](/filings/0001641172-25-010712.md) | [9.4](/filings/0001641172-25-024046.md) | [7.0](/filings/0001493152-25-023374.md) | [6.2](/filings/0001493152-26-038447.md) | [4.9](/filings/0001493152-26-023865.md) | [4.1](/filings/0001493152-26-038447.md) |
| Current assets | $m | [24.4](/filings/0001493152-23-041176.md) | [74.6](/filings/0001641172-25-001576.md) | [72.2](/filings/0001493152-24-019277.md) | [67.7](/filings/0001493152-24-031643.md) | [68.8](/filings/0001493152-24-045198.md) | [66.7](/filings/0001493152-26-014231.md) | [52.8](/filings/0001641172-25-010712.md) | [18.9](/filings/0001641172-25-024046.md) | [17.1](/filings/0001493152-25-023374.md) | [14.3](/filings/0001493152-26-038447.md) | [10.7](/filings/0001493152-26-023865.md) | [9.4](/filings/0001493152-26-038447.md) |
| Total assets | $m | [197](/filings/0001493152-23-041176.md) | [153](/filings/0001641172-25-001576.md) | [149](/filings/0001493152-24-019277.md) | [144](/filings/0001493152-24-031643.md) | [143](/filings/0001493152-24-045198.md) | [106](/filings/0001493152-26-014231.md) | [92.4](/filings/0001641172-25-010712.md) | [93.4](/filings/0001641172-25-024046.md) | [92.1](/filings/0001493152-25-023374.md) | [67.6](/filings/0001493152-26-038447.md) | [71.3](/filings/0001493152-26-023865.md) | [68.4](/filings/0001493152-26-038447.md) |
| Current liabilities | $m | [53.5](/filings/0001493152-23-041176.md) | [55.6](/filings/0001641172-25-001576.md) | [56.2](/filings/0001493152-24-019277.md) | [57.7](/filings/0001493152-24-031643.md) | [59.1](/filings/0001493152-24-045198.md) | [65.0](/filings/0001493152-26-014231.md) | [54.0](/filings/0001641172-25-010712.md) | [53.8](/filings/0001641172-25-024046.md) | [54.2](/filings/0001493152-25-023374.md) | [47.5](/filings/0001493152-26-038447.md) | [47.7](/filings/0001493152-26-023865.md) | [49.2](/filings/0001493152-26-038447.md) |
| Total liabilities | $m | not reported | [70.0](/filings/0001493152-24-045198.md) | not reported | not reported | [73.0](/filings/0001493152-24-045198.md) | [73.7](/filings/0001493152-26-014231.md) | [62.6](/filings/0001641172-25-010712.md) | [66.0](/filings/0001641172-25-024046.md) | [66.0](/filings/0001493152-25-023374.md) | [58.9](/filings/0001493152-26-038447.md) | [58.7](/filings/0001493152-26-023865.md) | [59.9](/filings/0001493152-26-038447.md) |
| Long-term debt | $m | [7.7](/filings/0001493152-23-041176.md) | [7.5](/filings/0001641172-25-001576.md) | [7.4](/filings/0001493152-24-019277.md) | [7.0](/filings/0001493152-24-031643.md) | [7.4](/filings/0001493152-24-045198.md) | [2.4](/filings/0001493152-26-014231.md) | [2.4](/filings/0001641172-25-010712.md) | [6.2](/filings/0001641172-25-024046.md) | [6.0](/filings/0001493152-25-023374.md) | [5.7](/filings/0001493152-26-038447.md) | [5.5](/filings/0001493152-26-023865.md) | [5.3](/filings/0001493152-26-038447.md) |
| Current portion of debt | $m | [46.6](/filings/0001493152-23-041176.md) | [47.8](/filings/0001493152-24-045198.md) | [47.5](/filings/0001493152-24-019277.md) | [49.1](/filings/0001493152-24-031643.md) | [49.9](/filings/0001493152-24-045198.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [94.3](/filings/0001493152-23-041176.md) | [63.9](/filings/0001641172-25-001576.md) | [59.9](/filings/0001493152-24-019277.md) | [55.2](/filings/0001493152-24-031643.md) | [52.1](/filings/0001493152-24-045198.md) | [19.9](/filings/0001493152-26-014231.md) | [17.9](/filings/0001641172-25-010712.md) | [15.7](/filings/0001641172-25-024046.md) | [14.2](/filings/0001493152-25-023374.md) | [(0.8)](/filings/0001493152-26-038447.md) | [3.4](/filings/0001493152-26-023865.md) | [(0.4)](/filings/0001493152-26-038447.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,320) d](/filings/0001493152-24-045198.md) | [1,841 d](/filings/0001641172-25-001576.md) | [(2,150)](/filings/0001641172-25-010712.md) | [(3,424) d](/filings/0001641172-25-024046.md) | [(315) d](/filings/0001493152-25-023374.md) | [(2,872) d](/filings/0001493152-26-014231.md) | [168](/filings/0001493152-26-023865.md) | [(622) d](/filings/0001493152-26-038447.md) | [(7,122) d](/filings/0001493152-25-023374.md) | [(1,553) d](/filings/0001493152-26-014231.md) | [(133)](/filings/0001493152-26-023865.md) | [(1,852) d](/filings/0001493152-26-038447.md) |
| Capital expenditure | $k | [67.0](/filings/0001493152-23-041176.md) | [139 d](/filings/0001641172-25-001576.md) | [3.0](/filings/0001641172-25-010712.md) | [26.0 d](/filings/0001641172-25-024046.md) | [0.0 d](/filings/0001493152-25-023374.md) | [104 d](/filings/0001641172-25-001576.md) | [52.0](/filings/0001641172-25-010712.md) | [92.0 d](/filings/0001641172-25-024046.md) | [82.0 d](/filings/0001493152-25-023374.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [135](/filings/0001493152-23-041176.md) | [7.0](/filings/0001493152-24-019277.md) | [7.0](/filings/0001493152-24-031643.md) | [7.0](/filings/0001493152-24-045198.md) | [7.1](/filings/0001641172-25-010712.md) | [7.1](/filings/0001641172-25-024046.md) | [7.1](/filings/0001493152-25-023374.md) | [8.7](/filings/0001493152-26-023865.md) | [9.1](/filings/0001493152-26-038447.md) | [9.1](/filings/0001493152-25-023374.md) | [9.6](/filings/0001493152-26-023865.md) | [10.0](/filings/0001493152-26-038447.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,042,518 at 2026-08-05, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038447.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.